Galectin Therapeutics (GALT) Total Non-Current Liabilities (2010 - 2026)
Galectin Therapeutics (GALT) recorded Total Non-Current Liabilities of $153.34 million in Q2 2026, up 15.3% from $132.96 million a year earlier and up 5.9% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics reported Total Non-Current Liabilities of $143.49 million, up 17.4% from FY2024.
- Annual Total Non-Current Liabilities has increased for seven straight years, with a five-year compound annual growth rate of 82.3% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $122.24 million in FY2024 (+37.1%), $89.16 million in FY2023 (+63.2%), $54.63 million in FY2022 (+37.2%) and $39.8 million in FY2021 (+458.9%).
- The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2010.
- On a year-over-year basis, Total Non-Current Liabilities has increased for 27 consecutive quarters, with growth averaging 33.5% over the last eight quarters.
- The year-over-year growth in Total Non-Current Liabilities has ranged between 8.1% (Q1 2024) and 596.3% (Q3 2021) over the last five years.
- Per Business Quant, the preceding three quarters came in at $144.74 million (Q1 2026), $143.49 million (Q4 2025) and $138.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.36 Bn | 1,105.95 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 617.62 Bn | 536.15 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 501.17 Bn | 474.28 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 368.13 Bn | 322.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.23 Bn | 234.92 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.68 Bn | 192.08 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Galectin Therapeutics | 222.00 Mn | 165.34 Mn | - | 153.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153.34 Mn |
| Mar 31, 2026 | 144.74 Mn |
| Dec 31, 2025 | 143.49 Mn |
| Sep 30, 2025 | 138.17 Mn |
| Jun 30, 2025 | 132.96 Mn |
| Mar 31, 2025 | 123.38 Mn |
| Dec 31, 2024 | 122.24 Mn |
| Sep 30, 2024 | 121.02 Mn |
| Jun 30, 2024 | 109.76 Mn |
| Mar 31, 2024 | 68.38 Mn |
| Dec 31, 2023 | 89.14 Mn |
| Sep 30, 2023 | 73.39 Mn |
| Jun 30, 2023 | 72.04 Mn |
| Mar 31, 2023 | 63.20 Mn |
| Dec 31, 2022 | 54.56 Mn |
| Sep 30, 2022 | 41.05 Mn |
| Jun 30, 2022 | 42.12 Mn |
| Mar 31, 2022 | 40.53 Mn |
| Dec 31, 2021 | 39.80 Mn |
| Sep 30, 2021 | 29.32 Mn |
API Access
Galectin Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();